The Journal of Laryngology & Otology · 1992 · 48 citations · 7 references
MedicineCancer BiologyOncologyNeoplasiaSalivary Gland DisordersTumor PathologyImmunohistochemistryMalignant Salivary Gland TumorsSalivary Gland CancerSalivary Gland MalignanciesSalivary Gland PathologySalivary GlandsImmunohistochemical DetectionImmunohistochemical MarkersImmunohistochemical StainingKi-67 ImmunostainingPleomorphic Adenoma CarcinomaSalivary Gland HistochemistrySalivary Gland MorphologySalivary Gland Tumor Cytology
Using Ki-67, a monoclonal antibody, the proliferating capacity of 15 salivary gland tumours, including nine pleomorphic adenomas, four adenoid cystic carcinomas, one mucoepidermoid carcinoma and one acinic cell carcinoma was determined immunohistochemically, using normal salivary gland tissue as a control. The frequency of Ki-67 positive cells was 4.7 percent in the normal salivary gland and one percent in pleomorphic adenomas, whereas the average frequency in malignant tumours was 18.3 percent. Among adenoid cystic carcinomas, the frequency was related to the morphological type; the solid sub-type had the highest frequency of Ki-67-positive cells. As this sub-type is recognized as the most aggressive of these tumours, this technique has the potential of providing an early indication of the clinical behaviour of a tumour.
7
Ludwig A. Sternberger, Paul H. Hardy, John J. Cuculis et al. · Journal of Histochemistry & Cytochemistry · 1970 · 5.1K citations · Full text
The prognostic value of Ki67 immunostaining in non‐Hodgkin's lymphoma
Peter A. Hall, Martin Richards, W. Gregory et al. · The Journal of Pathology · 1988 · 312 citations